Skip to main content
Publications
Goyal RK Davis KL Treatment patterns and resource utilization among patients with HR+/HER2– metastatic breast cancer in a privately insured US population
Goyal RK Davis KL Treatment patterns and resource utilization among elderly Medicare patients with HR+/HER2– metastatic breast cancer
Fuertes E, Standl M, Forns J Traffic-related air pollution and hyperactivity/inattention, dyslexia and dyscalculia in adolescents of the German GINIplus and LISAplus birth cohorts 10.1016/j.envint.2016.10.017
DaSilva T, Gonik B, Mcmillan M, Keech C, Dellicour S, Bhange S, Tila M, Harper DM, Woods C, Kawai AT Stillbirth: case definition and guidelines for data collection, analysis, and presentation of maternal immunization safety data 10.1016/j.vaccine.2016.03.044
Fernandez-Barres S, Romaguera D, Valvi D, Martinez D Mediterranean dietary pattern in pregnant women and offspring risk of overweight and abdominal obesity in early childhood: the INMA birth cohort study 10.1111/ijpo.12092
Anthony L, Horsch D, Ervin C DiBenedetti D Assessing treatment benefit of telotristat etiprate in patients with carcinoid syndrome: patient exit interviews 10.1530/endoabs.46.P11
DeSilva M, Munoz FM, Mcmillan M, Kawai AT Congenital anomalies: case definition and guidelines for data collection, analysis, and presentation of immunization safety data 10.1016/j.vaccine.2016.03.047
Abdul-Jawad Altisent O, Durand E, Munoz-Garcia AJ, Nombela-Franco L, Cheema A, Kefer J, Gutierrez E, Benitez LM, Amat-Santos IJ, Serra V, Eltchaninoff H, Alnasser SM, Elizaga J, Dager A, Garcia Del Blanco B, Ortas-Nadal MDR, Marsal JR Reply: antithrombotic regimen in post-TAVR atrial fibrillation: not an easy decision 10.1016/j.jcin.2016.09.038
Llop S, Ballester F, Murcia M, Forns J Prenatal exposure to mercury and neuropsychological development in young children: the role of fish consumption 10.1093/ije/dyw259
Strober B, Blauvelt A, Zhao Y, Milutinovic M, Mollon P, You R, Sherif B Secukinumab provides better relief from psoriasis-related pain, itching, and scaling than ustekinumab
Korman N, Sofen H, Rich P, Fretzin S, Zhao Y, Herrera V, Mordin M Secukinumab provides better relief from psoriasis impact on personal relationships than etanercept
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides better relief from quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides better relief from quality-of-life impact than placebo in moderate to severe psoriasis
Blauvelt A, Korman N, Mollon P, Zhao Y, Milutinovic M, You R, Sherif B Secukinumab provides faster and better quality of life impact than ustekinumab in psoriasis
Korman N, Sofen H, Rich P, Fretzin S, Zhao Y, Herrera V, Mordin M Secukinumab provides more effective relief from psoriasis impact on personal relationships and influence on clothes worn than etanercept and placebo
Tyring S, Sofen H, Fretzin S, Rich P, Zhao Y, Herrera V, Sherif B Secukinumab provides more effective relief from skin-related quality-of-life impact than etanercept in moderate to severe psoriasis
Sofen H, Korman N, Rich P, Fretzin S, Zhao Y, Herrera V, Sherif B McLeod L Secukinumab provides more effective relief from skin-related quality-of-life impact than placebo in moderate to severe psoriasis
Balp M, Abuzakouk M, Berard F, Canonica GW, Gimenez-Arnau A, Hollis K Comparison of direct healthcare costs associated with chronic spontaneous/idiopathic urticaria in 7 countries - results from the ASSURE-CSU study
